Since the end of the 1990’s, the pharmaceutical industry has seen an increased interest in biologics, especially in the therapeutic areas of oncology and inflammation. The selection of potent and selective Mabs (monoclonal antibodies) for specific target receptors, such as Receptor Tyrosine Kinase (RTK) and G protein-coupled receptors (GPCRs), is the first step in successfully developing an antibody based drug. In addition to potent binding, some antibodies have the ability to recruit the immune system effector cells, a process known as ADCC (Antibody Dependent Cell Cytotoxicity). The ability to promote ADCC is an important attribute of successful candidates and for that reason should be sought in the final drug design.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
High-throughput Carbonic Anhydrase Activity and Inhibitor Screening Assays
Suratna Hazra, Ph.D., Grigoriy Tchaga, Ph.D., and Gordon Yan, Ph.D.
A High-Throughput Assay to Measure Phosphoenolpyruvate Carboxykinase (PEPCK) Activity in Biological Samples
Shunan Li, Ph.D., Keith Cheung, Ph.D. Grigoriy Tchaga, Ph.D. Jianping Xu, Ph.D. and Gordon Yan, Ph.D. Acknowledments: Kyle Schmitt, Ph.D • Tanvi Gangakhedkar • Gustavo Chavarria, Ph.D. • Kwang Kim, Ph.D. • Robert Stephenson, Ph.D. • Hong Qu, Ph.D.
High-throughput detection of Glycine in biological samples based on a novel enzymatic assay
Gustavo Chavarria, Ph.D., Kyle Schmitt, Ph.D., Nidhi Tibrewal, Ph.D., Sonika Saddar, Ph.D., Preeti Saini, Ph.D., Grigoriy Tchaga, Ph.D. and Gordon Yan, Ph.D.
A High-throughput, Fluorescence-based Cholesterol Efflux Assay
Sonika Saddar, Tasnim Kothambawala, Nick Chacos, Preeti Saini, Grigoriy Tchaga and Gordon Yan
Circulating Oxidized Mitochondrial DNA is an Index of Pyroptotic Cell Death in Patients with Myelodysplastic Syndrome.
Grace A. Ward B.S., Kathy L. McGraw PhD., Ashley A. Basiorka PhD., Alan F. List M.D.